RBC Capital raises Ducommun stock price target on defense growth By Investing.com

RBC Capital raised its Ducommun (DCO) price target to $150 from $142, based on a 13.5x multiple on its 2028 adj. EBITDA estimate; the stock trades at $129.59 with a $1.92B market cap and has returned 112% over the past year. Ducommun reported Q4 2025 adjusted EPS of $1.05 (beat $0.96) while revenue of $215.8M missed $217.35M. RBC highlights increasing defense (missiles/munitions) exposure and expects growth to accelerate in 2027-2028 with a likely mid-term margin reset at the 3Q26 investor day.

Analysis

Ducommun’s repositioning toward missile and munitions content creates a playbook where program timing and inventory cycles matter more than headline revenue growth. If missile kit volume ramps are backloaded, DCO can see compressed near-term margins as it hires and qual’s suppliers ahead of revenue — a classic working-capital and margin phasing issue that tends to create volatile quarter-to-quarter EPS beats and misses.

Second-order winners include precision fastener/composite shops and EMS providers that can scale to defense lot sizes quickly; second-order losers are high-fixed-cost commercial aerospace suppliers that face delayed aircraft production and will underperform if capital shifts into defense. Expect raw-material and labor tightness in specific subcomponents (precision machined parts, specialty adhesives) to push smaller suppliers into premium pricing or longer lead times, which benefits integrators with diversified capacity.

Key catalysts and risks are calendarized: near-term sentiment swings around quarterly prints and the company investor day, medium-term visibility from contract awards and backlog conversion over 6–24 months, and longer-term structural funding risks from defense budget reprioritization. Tail risks that would reverse the bullish narrative include abrupt program funding cuts, export-control-driven order delays, or a broader industrial de-risking that re-routes missile spend to vertically integrated primes rather than tier‑2 suppliers.

The consensus overlooks a binary margin reset risk tied to how Ducommun transitions from doing lower-margin original equipment work to higher-margin ordnance assemblies; if the mix shift lags, multiples already priced for growth compress quickly. That makes asymmetric option structures and event-timed exposure more attractive than outright long equity here.

Key Decisions for Investors

• Directional long stock (DCO): Buy on a pullback into the low‑40% retracement from the recent run-up, horizon 6–12 months; target 30–40% upside if backlog converts, stop at 12–15% to limit exposure to margin-reset risk.
• Event-driven call spread (DCO): Buy 12–18 month call spread (e.g., buy long-dated near-the-money call, sell higher strike) to capture funded program roll-through while capping premium — expect 2–3x payoff if management shows sustainable margin trajectory at investor day, max loss = premium paid.
• Pair trade (long DCO / short commercial-exposed supplier): Long DCO vs short a commercial-aviation‑lean supplier (e.g., high commercial OEM supplier ticker) sized dollar-neutral, 6–12 month horizon — hedge macro aviation cyclicality and profit from defense share reallocation.
• Volatility hedge: Buy 6–9 month puts or put spreads on DCO ahead of the investor day and next two quarters to protect against a downside revision; cost should be underwritten by selling shorter-dated calls if comfortable capping upside.
• Supply-chain play: Long select precision sub-tier suppliers with scalable capacity (tickers: small caps with >50% defense exposure), 12–24 month horizon — these can outpace Ducommun on margin expansion if they capture incremental missile content, but size positions small given execution risk.